These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24310505)

  • 1. Clinical significance of serum transforming growth factor-beta 1 (TGF-β1) levels in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3611-6. PubMed ID: 24310505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patients.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3327-31. PubMed ID: 24272203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3125-32. PubMed ID: 24254307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum transforming growth factor-beta 1 (TGF-β1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma.
    Tas F; Karabulut S; Yasasever CT; Duranyildiz D
    Tumour Biol; 2014 Jul; 35(7):7233-7. PubMed ID: 24771267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.
    Tas F; Yasasever CT; Karabulut S; Tastekin D; Duranyildiz D
    Tumour Biol; 2015 Mar; 36(3):2097-103. PubMed ID: 25391430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum level of epidermal growth factor receptor (EGFR) is associated with poor progression-free survival in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):631-7. PubMed ID: 24477605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer.
    Didem T; Faruk T; Senem K; Derya D; Murat S; Murat G; Oznur K
    Tumour Biol; 2014 Jul; 35(7):6777-82. PubMed ID: 24722824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3095-102. PubMed ID: 24307621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.
    Yildiz I; Tas F; Kilic L; Sen F; Saip P; Eralp Y; Keskin S; Karabulut S; Ciftci R; Serilmez M; Yasasever V; Aydiner A
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):437-44. PubMed ID: 23801282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-optimal primary surgery leads to unfavorable immunological changes in ovarian cancer patients.
    Nowak M; Głowacka E; Lewkowicz P; Banasik M; Szyłło K; Zimna K; Bednarska K; Klink M
    Immunobiology; 2018 Jan; 223(1):1-7. PubMed ID: 29017822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
    Huo J; Hu J; Liu G; Cui Y; Ju Y
    Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.
    Bozas G; Terpos E; Gika D; Karadimou A; Dimopoulos MA; Bamias A
    Int J Gynecol Cancer; 2010 Feb; 20(2):248-54. PubMed ID: 20134268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?
    Karabulut S; Akşit E; Tas F; Ciftci R; Aydiner A; Yildiz I; Keskin S; Eralp Y; Yasasever CT; Vatansever S; Disci R; Saip P
    Tumour Biol; 2014 May; 35(5):4323-9. PubMed ID: 24390664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Oncotarget; 2016 Mar; 7(13):16923-35. PubMed ID: 26943577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer.
    Tas F; Kilic L; Bilgin E; Keskin S; Sen F; Ciftci R; Yildiz I; Yasasever V
    Int J Gynecol Cancer; 2013 Feb; 23(2):276-81. PubMed ID: 23266651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.
    Luo Y; Kim HS; Kim M; Lee M; Song YS
    J Gynecol Oncol; 2017 May; 28(3):e36. PubMed ID: 28382799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC).
    Rohr I; Braicu EI; En-Nia A; Heinrich M; Richter R; Chekerov R; Dechend R; Heidecke H; Dragun D; Schäfer R; Gorny X; Lindquist JA; Brandt S; Sehouli J; Mertens PR
    Cytokine; 2016 Sep; 85():157-64. PubMed ID: 27371774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
    Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.